Skip to Main Content
Back to News

Proto Labs Stock (PRLB) Opinions on Record Q2 Revenue Results

None

Recent discussions on X about Proto Labs (PRLB) have centered around the company’s strong quarterly performance and insider activity. Many users have highlighted the impressive Q2 revenue of $135.1 million, which exceeded analyst expectations and triggered a significant jump in stock price. The sentiment reflects a sense of optimism as investors react to these record results.

Additionally, there’s buzz around insider buying, with the CEO’s recent purchase of shares worth approximately $75,000 drawing attention on the platform. Some users interpret this as a strong signal of confidence in the company’s future, while others remain cautious, awaiting further market reactions. The conversation also touches on analyst upgrades, with a notable shift to a 'strong-buy' rating fueling further interest.

Note: This discussion summary was generated from an AI condensation of post data.

Proto Labs Insider Trading Activity

Proto Labs insiders have traded $PRLB stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $PRLB stock by insiders over the last 6 months:

  • SURESH KRISHNA (President and CEO) purchased 1,725 shares for an estimated $75,054

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

Proto Labs Hedge Fund Activity

We have seen 87 institutional investors add shares of Proto Labs stock to their portfolio, and 102 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

Proto Labs Government Contracts

We have seen $203,148 of award payments to $PRLB over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.

Proto Labs Analyst Ratings

Wall Street analysts have issued reports on $PRLB in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Cantor Fitzgerald issued a "Overweight" rating on 02/10/2025

To track analyst ratings and price targets for Proto Labs, check out Quiver Quantitative's $PRLB forecast page.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles